Pantoprazole Affecting Docetaxel Resistance Pathways via Autophagy (PANDORA): Phase II Trial of High Dose Pantoprazole (Autophagy Inhibitor) With Docetaxel in Metastatic Castration‐Resistant Prostate Cancer (mCRPC)
Oncologist - United States
doi 10.1634/theoncologist.2018-0621
Full Text
Open PDFAbstract
Available in full text
Date
April 5, 2019
Authors
Publisher
Alphamed Press